| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |